09/11/2023
Significant efficacy of RUTI® vaccine in a non-clinical study of active tuberculosis
A recent non-clinical study has demonstrated the potential of the therapeutic vaccine RUTI® in treating…
Read More
24/03/2023
World TB Day
Today is #WorldTBDay, a day to raise awareness about the devastating impact of #tuberculosis –…
Read More
15/02/2023
The STRITUVAD project has been completed
The STRITUVAD (In Silico TRIals for TUberculosis VAccine Development) project has been completed. It has…
Read More
30/09/2022
A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine
A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment…
Read More
22/10/2021
The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB)
The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic…
Read More
08/04/2020
Archivel Farma’s RUTI® vaccine to start a clinical trial to increase the immunity of healthcare professionals exposed to the risk of COVID-19
The clinical trial will be carried out at the Germans Trias i Pujol Hospital in…
Read More
05/11/2019
Extension of the authorization for the manufacture of medicines
As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization…
Read More
20/02/2019
Archivel Farma at the annual TBVI meeting
On January 29, Archivel Farma, represented by its CEO, Olga Rúe, and Dr. Pere Joan…
Read More
04/02/2019
Inauguration meeting of STriTuVaD project
Olga Rue, CEO of Archivel Farma, and Dr Pere Joan Cardona, Scientific advisor of the…
Read More
15/01/2019
Archivel participates in the STriTuVaD consortium
Archivel Farma is one of the eight partners of STriTuVad consortium, whose overall goal is…
Read More
Archivel on the media
TV3, QuèQuiCom
2016
